{"id":75231,"date":"2023-06-24T22:44:59","date_gmt":"2023-06-24T22:44:59","guid":{"rendered":"https:\/\/dailytalks.org\/?p=75231"},"modified":"2023-06-24T22:44:59","modified_gmt":"2023-06-24T22:44:59","slug":"semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=75231","title":{"rendered":"Semaglutide Use Improves Cardiovascular Risk Score in Overweight Patients"},"content":{"rendered":"<p>New research presented at this year\u2019s European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use. The study is by Dr Andres Acosta and Dr Wissam Ghusn, Precision Medicine for Obesity Program at the Mayo Clinic, Rochester, MN<br \/><a href=\"https:\/\/www.miragenews.com\/semaglutide-use-improves-cardiovascular-risk-1010240\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>New research presented at this year\u2019s European Congress on Obesity in Dublin, Ireland shows that<\/p>\n","protected":false},"author":1,"featured_media":75232,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-75231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-scaled.jpg",2560,1704,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-300x200.jpg",300,200,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-768x511.jpg",640,426,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-1024x682.jpg",640,426,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-1536x1023.jpg",1536,1023,true],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-2048x1364.jpg",2048,1364,true],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-1024x682.jpg",1024,682,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/06\/75231-semaglutide-use-improves-cardiovascular-risk-score-in-overweight-patients-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=16\" rel=\"category\">Europe<\/a>","tag_info":"Europe","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/75231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75231"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/75231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/75232"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}